Template:Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) No edit summary |
Dima Nimri (talk | contribs) No edit summary |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | ||
|- | |||
| colspan="1" style="text-align:center; background:DarkGray" |'''ICD Guidelines<br> Microchapters''' | |||
|- bgcolor="LightGrey" | |||
! | |||
|- bgcolor="Coral" | |- bgcolor="Coral" | ||
! | ! | ||
[[ | [[ICD|ICD Main Page]] | ||
|- | |- | ||
! | ! | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightCoral" | | | colspan="1" style="text-align:center; background:LightCoral" | '''Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities''' | ||
Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities | |||
|- | |- | ||
! | ! | ||
| Line 15: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[ICD guidelines|Implantable Cardioverter-Defibrillators]] | ||
|- | |- | ||
! | ! | ||
| Line 21: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[ICD in pediatric patients with congenital heart disease|Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease]] | ||
|- | |- | ||
! | ! | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:CornFlowerBlue" | | | colspan="1" style="text-align:center; background:CornFlowerBlue" | '''Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials''' | ||
Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials | |||
|- | |- | ||
! | ! | ||
| Line 35: | Line 33: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[ICD in the context of abnormal troponin|ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction]] | ||
|- | |- | ||
! | ! | ||
| Line 41: | Line 39: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[ICD implantation within 40 days of myocardial infarction|ICD Implantation Within 40 Days of a Myocardial Infarction]] | ||
|- | |- | ||
! | ! | ||
| Line 47: | Line 45: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[ICD within 90 days of revascularization|ICD Implantation Within 90 Days of Revascularization]] | ||
|- | |- | ||
! | ! | ||
| Line 53: | Line 51: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[ICD less than 9 months from diagnosis of nonischemic cardiomyopathy|ICD Implantation Less Than 9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy]] | ||
|- | |- | ||
! | ! | ||
|} | |} | ||
Latest revision as of 17:23, 26 October 2016
| ICD Guidelines Microchapters |
| Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities |
| Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials |
|
ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction |
|
ICD Implantation Less Than 9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy |